Torrent Pharmaceuticals
Torrent Pharmaceuticals
Shareholder Return: 3-year, Sales Growth: 3-year CAGR, Return On Equity: 3-year average
At a Glance
-
Shareholder Return294%
-
Sales Growth20%
-
Return on Equity36 %
Why Super 50
The company is a favourite among analysts for its robust track record of execution and strong balance sheet. It has a strong focus on India and the US markets. The company, which raised about Rs 10,000 crore by issuing securities this January, has said it is open to acquisitions to fuel growth.
